T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF
$33.89−0.78 (−2.25%)
- Expense ratio
- 0.44%
- Fund size
- $32M
- 1Y return
- +33.6%
- Yield · Last 12 months
- Data unavailable
- Volume · 30D
- 0M sh
- NAV per share
- $34.21
- 52W range
The ETF.net TMED Grade
Score 65 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 82Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 55Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.DScore 38Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.AScore 87Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.DScore 36Category rank
TMED Holdings
- Stocks
- —
- 41%
- LLY.TO
Sectors
- Health Care99.9%
- Technology0.1%
Geography
- United States93.03%
- Germany2.19%
- Denmark2.00%
- Switzerland1.43%
- United Kingdom0.73%
- Canada0.27%
- Italy0.21%
- China0.08%
- 0.05%
TMED Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | TMED |
|---|---|
| Year to date | +16.7% |
| 1 month | −4.5% |
| 3 months | +8.2% |
| 1 year | +33.6% |
| 3 years | — |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | TMED |
|---|---|---|
| 2026 YTD | +16.7% | |
| 2025 | +18.9% |
TMED in the news
ETF.net Research hasn’t filed on TMED yet — coverage lands here as it’s written.
TMED Dividends
- $0.16 per share
- Irregular
Distribution data unavailable.
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Dec 23, 2025 | Dec 26, 2025 | $0.16 |
TMED Risk
- 14.4%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 1.98
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −11.1%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.46
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
TMED Cost
- The middle half of US Active Sector funds
- Median 0.65%
6 of the 33 US Active Sector funds charge less.